Cerebral Cortical and White Matter Lesions in Chronic Hepatic Encephalopathy: MR-Pathologic Correlations
|
|
|
- Bennett Pitts
- 10 years ago
- Views:
Transcription
1 AJNR Am J Neuroradiol 26: , February 2005 Case Report Cerebral Cortical and White Matter Lesions in Chronic Hepatic Encephalopathy: MR-Pathologic Correlations Eiji Matsusue, Toshibumi Kinoshita, Eisaku Ohama, and Toshihide Ogawa Summary: We correlated MR images with histologic findings in two autopsy-proven cases of chronic hepatic encephalopathy. Cortical hyperintensities on T2-weighted images histologically revealed pseudolaminar spongy degeneration in the deep layers of the cerebral cortices and hyperintensities in the cerebral white matters showed tissue rarefaction associated with loss of myelin and axons but without reactive astrocytosis. Both lesions were considered to be caused by chronic hepatic encephalopathy. Hepatic encephalopathy is a complication of hepatic failure or portosystemic shunt surgery. Clinical features include confusion, which is often associated with a flapping tremor, drowsiness, stupor, and coma. Repeated episodes of hepatic encephalopathy may lead to neuropsychiatric disturbances, dysarthria, ataxia, and choreoathetosis (1). Pathologically, brain edema without inflammatory infiltration is characteristic of an acute stage, whereas Alzheimer type II astrocytes, which have large pale nuclei with marginated chromatin and scanty cytoplasm, in the gray matter and pseudolaminar spongy degeneration in the deep layers of the cerebral cortices are characteristic findings in the chronic stage (2). The Alzheimer type II astrocytes are largely due to hyperammonemia, which is probably also directly or indirectly responsible for neuronal damage, although the pathogenesis of hepatic encephalopathy is not fully elucidated (3, 4). Hyperintensities in the bilateral globi pallidi on T1-weighted images have been established as a characteristic finding on MR images in chronic hepatic encephalopathy (5). MR spectroscopy has been available for detecting specific biochemical alterations, which consist of the increase in cerebral glutamine and glutamamate (Glx) and the decrease in myoinositol (mi) and choline (Cho) metabolites in chronic hepatic encephalopathy (6). A few MR imaging studies have described brain swelling and diffuse cortical lesions in acute hepatic encephalopathy (7, 8). There Received April 3, 2004; accepted after revision June 1. From the Division of Radiology, Department of Pathophysiological and Therapeutic Science (E.M., T.K., T.O.), and the Department of Neuropathology, Institute of Neurological Sciences (E.M., E.O.), Faculty of Medicine, Tottori University, Yonago, Japan. Address correspondence to Eiji Matsusue, MD, Faculty of Medicine, Tottori University, 36-1 Nishi-cho, Yonago, Tottori , Japan. American Society of Neuroradiology has so far been no report studying the correlation of MR images with histologic findings in patients with chronic hepatic encephalopathy. We studied MRpathologic correlations with a focus on hyperintensities on the antemortem and postmortem T2-weighted images and their histologic findings in two autopsyproven cases of chronic hepatic encephalopathy. Case 1 The patient was a 75-year-old woman. Family history was unremarkable for neuropsychiatric disease. At the age of 56 years, she suffered atonic seizure, gait instability, and intention tremor. At ages 66 and 72 years, she developed disturbance of consciousness and was admitted to the hospital, but her symptoms soon subsided without treatment. MR images obtained when the patient was 72 years of age showed hyperintensities in the bilateral globi pallidi on T1-weighted images and slight hyperintensities in some cerebral cortices, as well as confluent and diffuse hyperintensities in the deep and subcortical cerebral white matter on T2-weighted images (Fig 1A F). Seven months later, she was readmitted to the hospital because of disorientation. Laboratory examinations showed marked hyperammonemia (227 g/dl; normal range, g/dl). Electroencephalography (EEG) revealed triphasic wave. Her condition was diagnosed as chronic hepatic encephalopathy. Over the next 3 years, she had repeated disturbance of consciousness and disorientation, and she responded less positively to treatment. She died of respiratory failure at the age of 75 years. The total duration from the onset of hepatic encephalopathy to her death was 19 years. Autopsy was limited to the brain and liver. The liver, weighing 650 g after fixation, revealed fatty cirrhosis. The brain, weighing 1100 g after fixation, showed slight cerebral atrophy. Histologic examination showed numerous Alzheimer type II astrocytes in the cerebral cortices, putamen, caudate nucleus, globus pallidus, thalamus, and cerebellar dentate nucleus as well as in the substantia nigra and inferior olivary nucleus. Pseudolaminar spongy degeneration was found in the deep layers of cerebral cortices and the underlying U-fibers. Neurons were pyknotic and shrunken in the cerebral cortices, but those in the Ammon s horns were well preserved. There was tissue rarefaction with moderate loss of myelin and axons, but without reactive astrocytosis and no arterio- and arteriolosclerosis in the cerebral white matters. MR images of the formalin-fixed brains (postmortem MR images) were obtained by using a 1.5T system. The fixed brains were positioned in a standard way in the head coil and axial and coronal fast spin-echo T2-weighted images (TR/TE, 3500/96; thickness/gap, 4/1) were obtained. Postmortem T2-weighted MR images showed deep cortical and subcortical laminar hyperintensities in the entire cerebral hemisphere (Fig 1G I). Hyperintensities were also seen in the deep and subcortical white matters (Fig 1G I). The laminar hyperintensities in the deep cortical layers and subcortical white matter on the postmortem coronal T2-weighted images showed laminar pallor of 347
2 348 MATSUSUE AJNR: 26, February 2005 FIG 1. Case 1. A C, Axial T1-weighted MR images obtained 2 days after admission. T1-weighted image (A) shows hyperintensities in the globus pallidus on both sides (arrows). T1-weighted images show no definite signal intensity changes in the cerebral cortices (A C). D F, T2-weighted MR images obtained 2 days after admission. Signal intensity abnormalities are difficult to discern on T2-weighted image (D). T2-weighted images (E and F) show focal, faint hyperintensities in the cerebral cortices (arrows). Confluent and diffuse T2 hyperintensities are seen in the deep and subcortical cerebral white matters (E). the deep layers of the cerebral cortices and the underlying U-fibers on histologic sections (Fig 1J, K). Histologic findings of the laminar pallor in the deep cortical layers revealed pseudolaminar spongy degeneration, pyknotic and shrunken neurons, and Alzheimer type II astrocytes associated with neutrophil rarefaction in the deep layers of the cerebral cortices (Fig 1L). Histologic findings of the laminar pallor of the underlying U-fibers showed loss of myelin and axons without reactive astrocytosis (Fig 1M, N). The hyperintensities in the deep and subcortical cerebral white matters on the postmortem T2-weighted images revealed histologically mild to moderate loss of myelin and axons without reactive astrocytosis (Fig 1O, P). Case 2 The patient was a 58-year-old woman who received a blood transfusion during a caesarean section at 23 years of age. At age 52 years, her condition was diagnosed as liver cirrhosis. Four years later, she was admitted to the hospital because of mental confusion and a flapping tremor. Laboratory examinations revealed hyperammonemia (164 g/dl). MR images showed hyperintensities in the bilateral globi pallidi on T1- weighted images and confluent hyperintensities in the deep and subcortical cerebral white matters on T2-weighted images, but no definite signal intensity changes in the cerebral cortices. Chronic hepatic encephalopathy was the diagnosis and the patient was treated with branched-chain amino acids and lactulose, and her symptoms soon subsided. Over the next 2 years, mental confusion occurred repeatedly and her condition gradually deteriorated. She had several general convulsions and died of hepatic coma. The total duration from the onset of the hepatic encephalopathy to her death was 2 years. Autopsy revealed mixed macro- and micronodular cirrhosis (480 g) associated with hepatocellular carcinoma in her liver. The brain showed mild diffuse swelling and weighted 1220 g after fixation. Histologic examination showed numerous Alzheimer type II astrocytes in the cerebral cortices, putamen, caudate nucleus, globus pallidus, claustrum, thalamus, and cerebellar dentate nucleus, as well as in the substantia nigra. Pseudolaminar spongy degeneration was seen in the deep layers of the bilateral frontal cortices. There was mild to moderate loss of myelin and axons without arterio- and arteriolosclerosis, infiltration of inflammatory cells, and reactive astrocytosis in the cerebral white matters. Postmortem T2-weighted MR images showed cortical laminar hyperintensities in the frontal lobes (Fig 2A C). Hyperintensities were also seen in the deep and subcortical white matters but were more widespread in case one than in case two (Fig 2A C). The laminar hyperintensities in the deep layers of the cerebral cortices on the postmortem coronal T2-weighted
3 AJNR: 26, February 2005 CHRONIC HEPATIC ENCEPHALOPATHY 349 FIG 1. Continued. G and H, Postmortem axial T2-weighted MR images show deep cortical and subcortical laminar hyperintensities in the entire cerebral hemisphere. Diffuse T2 hypertensities are seen in the deep and subcortical cerebral white matters (G). I and J, Coronal T2-weighted MR images show deep cortical and subcortical laminar hyperintensities in the entire cerebral hemisphere. Hyperintensities are also seen in the deep and subcortical white matters (J). Boxed area in panel I shows hyperintensities in the deep layers of the cerebral cortices and subcortical white matters (open arrows) as well as deep cerebral white matter. The boundary between deep layers of the cerebral cortex and subcortical white matter is not clear. K, The hematoxylin and eosin stained section corresponding to panel J shows laminar pallor of the deep layers of the cerebral cortex (arrowheads) and laminar pallor of the underlying U-fibers (arrows), as well as moderate pallor of the deep cerebral white matter. (Hematoxylin and eosin stain 100.) L, Histologic findings of the arrowhead area in panel K shows spongy changes of the neuropil, pyknotic, and shrunken neurons (arrowheads) and Alzheimer type II astrocytes (arrows), which have large pale nuclei with marginated chromatin and scanty cytoplasms. (Hematoxylin and eosin stain 100.) M and N, Histologic findings of the U-fibers (K, arrows) show tissue rarefaction and severe loss of myelin (M) and axons (N). (M, Klüver-Barrera stain 100; N, Bielschowsky stain 100.) O and P, Histologic findings of the circled area in panels J and K reveals moderate loss of myelin (O) and axons (P). (O, Klüver-Barrera stain 100; P, Bielschowsky stain 100.)
4 350 MATSUSUE AJNR: 26, February 2005 FIG 2. Case 2. A C, Postmortem axial (A and B) and coronal (C) T2-weighted MR images show cortical laminar hyperintensities in the frontal lobes (B and C, arrows). Hyperintensities are also seen in the deep and subcortical white matters. D, Boxed area in panel C shows laminar hyperintensities in the deep layers of the cerebral cortex (arrowheads). E, The hematoxylin and eosin-stained section corresponding to panel D shows laminar pallor of the deep layers of the cerebral cortex (arrowheads). U-fibers are well preserved in this case (D and E, arrows). F, Histologic findings of the arrowhead area panel E shows spongy changes of the neuropil, pyknotic, and shrunken neurons (arrowheads) and Alzheimer type II astrocytes (arrows). (Hematoxylin and eosin 100.) images showed laminar pallor of the deep layers of the cerebral cortices on histologic sections, whereas U-fibers were well preserved on both MR images and histologic sections (Fig 2D, E). Histologic findings of the laminar pallor in the deep cortical layers revealed pseudolaminar spongy degeneration, pyknotic and shrunken neurons, and Alzheimer type II astrocytes associated with neuropil rarefaction in the deep layers of the cerebral cortices (Fig 2F). The hyperintensities in the deep and subcortical cerebral white matters on the postmortem T2- weighted images revealed histologically mild to moderate loss of myelin and axons without reactive astrocytosis. The histologic features were of the same in nature in both cases but were more severe and widespread in case 1, in agreement with the postmortem MR images. Discussion In the present cases, the antemortem T2-weighted images obtained 3 years before death in case 1 showed slight laminar hyperintensities in limited frontal and parietal cortices but were more extensive on the postmortem T2-weighted images. The laminar hyperintensities on the postmortem MR images histologically corresponded to pseudolaminar spongy degeneration associated with numerous Alzheimer type II astrocytes in the deep layers of the cerebral cortices in both cases and also corresponded to loss of myelin and axons in the underlying U-fibers in case 1. These histologic findings are characteristic of chronic hepatic encephalopathy (2). It is well known that similar cortical laminar T2 hyperintensities are also present in cases of hypoxic-ischemic brain damage (9, 10). In hypoxic-ischemic encephalopathy, however, they are frequently located in the boundary zones of the cerebral cortices, reflecting hemodynamic factors, whereas in chronic hepatic encephalopathy, they are most striking in the superior parietal and posterior frontal convexities (2). A few MR imaging studies have reported that the extent of cortical laminar T2 hyperintensities in cases of acute hepatic encephalopathy does not accord with the territories of arterial perfusion (7, 8). In our cases, the cortical laminar T2 hyperintensities were located partially in the bilateral frontal lobes in case 2 and entirely in
5 AJNR: 26, February 2005 CHRONIC HEPATIC ENCEPHALOPATHY 351 the cerebral hemispheres in case 1. Thus, both the extent and histologic findings support the view that the cortical lesions were caused by chronic hepatic encephalopathy. T2 hyperintensities in the cerebral white matters found in our cases, histologically showing mild to moderate loss of myelin and axons are not always found in chronic hepatic encephalopathy. Chronic hypoxic-ischemic lesions, such as those in the white matter of Binswanger disease, produce similar MR images. In our cases, however, there were neither arterio- and arteriolosclerosis nor reactive astrocytosis, which are always found in chronic hypoxic-ischemic lesions. There have been few MR imaging studies describing the occurrence of T2 hyperintensities in the cerebral white matters in patients with chronic hepatic encephalopathy (11). It has also been reported that T2 hyperintensities in the cerebral white matter found in 11 patients with liver cirrhosis normalized after successful liver transplantation, suggesting that they may reflect mild edema (12). Furthermore, it has been reported that typical brain metabolic changes in eight patients with liver cirrhosis, decreased mi/creatine (Cr) and Cho/Cr ratios and an elevated Glx/Cr ratio, normalized after liver transplantation on MR spectra (6). In our cases, the cerebral white matter lesions were more widespread in the later stage of the illness and in case 1 with a 19-year clinical course, and arterio- and arteriolosclerosis were not found. These findings suggest that the white matter lesions are also caused by chronic hepatic encephalopathy and may be associated with edematous changes. Conclusion Focal or extensive laminar T2 hyperintensities in patients with chronic hepatic encephalopathy reflect pseudolaminar spongy degeneration involving the deep layers of the cerebral cortices and occasionally involving the underlying U-fibers. T2 hyperintensities in the cerebral white matter reflect loss of myelin and axons, which may be due to longstanding edema caused by chronic hepatic encephalopathy. Acknowledgments We wish to thank to Drs. Hajime Miyata and Makoto Ostuka for their valuable discussion. References 1. Rothstein JD, Herlong HF. Neurologic manifestations of hepatic disease. Neurol Clin 1989;7: Victor M, Adams RD, Cole M. The acquired (non-wilsonian) type of chronic hepatocerebral degeneration. Medicine (Baltimore) 1965;44: Butterworth RF, Giguere JF, Michaud J, et al. Ammonia: key factor in the pathogenesis of hepatic encephalopathy. Neurochem Pathol 1987;6: Hazell AS, Butterworth RF. Hepatic encephalopathy: an update of pathophysiologic mechanisms. Proc Soc Exp Biol Med 1999;222: Brunberg JA, Kanal E, Hirsch W, et al. Chronic acquired hepatic failure: MR imaging of the brain at 1.5T. AJNR Am J Neuroradiol 1991;12: Naegele T, Grodd W, Viebahn R, et al. MR imaging and (1)H spectroscopy of brain metabolites in hepatic encephalopathy: timecourse of renormalization after liver transplantation. Radiology 2000;216: Kinoshita T, Takahashi S, Ishii K, et al. Rey s syndrome with cortical laminar necrosis: MRI. Neuroradiology 1996;38: Arnold SM, Els T, Spreer J, et al. Acute hepatic encephalopathy with diffuse cortical lesions. Neuroradiology 2001;43: Sawada H, Udaka F, Seriu N, et al. MRI demonstration of cortical laminar necrosis and delayed white matter injury in anoxic encephalopathy. Neuroradiology 1990;32: Takahashi S, Higano S, Ishii K, et al. Hypoxic brain damage: cortical laminar necrosis and delayed changes in white matter at sequential MR imaging. Radiology 1993;189: Yuki N, Yoshioka A, Yamaya Y, et al. A case of portal-systemic shunt encephalopathy due to congenital portal vein hypoplasia presenting with abnormal cerebral white matter lesions on the MRI. Clinical Neurol (Japanese) 2002;42: Rovira A, Cordoba J, Sanpedro F, et al. Normalization of T2 signal abnormalities in hemispheric white matter with liver transplant. Neurology 2002;59:
Hepatic Encephalopathy, Hyperammonemia, and Current Treatment in ICU Room
Hepatic Encephalopathy, Hyperammonemia, and Current Treatment in ICU Room Assoc.Prof. Chan Sovandy Chairman by : Prof.So Saphy and Assoc Prof, Kim chhoung Hepatic Encephalopathy Hepatic (portal systemic
HEPATIC ENCEPHALOPATHY
HEPATIC ENCEPHALOPATHY Jan Albrecht Department of Neurotoxicology, Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland Brussels, July 14, 2009 DEFINITIONS: - HEPATIC ENCEPHALOPATHY (HE)
Motor dysfunction 2: Spinal cord injury and subcortical motor disorders ANATOMY REVIEW: Basal Ganglia
Motor dysfunction 2: Spinal cord injury and subcortical motor disorders ANATOMY REVIEW: Basal Ganglia A group of subcortical nuclei caudate, putamen, globus pallidus Caudate & Putamen = Neostriatum caudate
Anoxic Brain Injury and Neural Damage: Three Case Reports
Anoxic Brain Injury and Neural Damage: Three Case Reports Abstract Anoxic brain injury (ABI) is common and can occur in a wide variety of disorders. This neural injury is associated with significant and
NEUROIMAGING in Parkinsonian Syndromes
NEUROIMAGING in Parkinsonian Syndromes (Focus on Structural Techniques: CT and MRI) Dr. Roberto Cilia Parkinson Institute, ICP, Milan, Italy OUTLINE Primary Parkinsonism Idiopathic Parkinson s Disease
PE finding: Left side extremities mild weakness No traumatic wound No bloody otorrhea, nor rhinorrhea
Case report A 82-year-old man was suffered from sudden onset spasm of extremities then he fell down to the ground with loss of consciousness. He recovered his consciousness 7-8 mins later but his conscious
NEURO M203 & BIOMED M263 WINTER 2014
NEURO M203 & BIOMED M263 WINTER 2014 MRI Lab 1: Structural and Functional Anatomy During today s lab, you will work with and view the structural and functional imaging data collected from the scanning
Reversible Delayed Leukoencephalopathy after Heroin Intoxication with Hypoxia: A Case Report
198 Reversible Delayed Leukoencephalopathy after Heroin Intoxication with Hypoxia: A Case Report Wei-Lun Chang 1, Yu-Kang Chang 2, Sen-Yen Hsu 3, Gua-Jang Lin 4, and Shih-Cheng Chen 1 Abstract- Delayed
Case Report. Central Neurocytoma. Fotis Souslian, MD; Dino Terzic, MD; Ramachandra Tummala, MD. Department of Neurosurgery, University of Minnesota
1 Case Report Central Neurocytoma Fotis, MD; Dino Terzic, MD; Ramachandra Tummala, MD Department of Neurosurgery, University of Minnesota Case This is a previously healthy 20 year old female, with 3 months
NP/PA Clinical Hepatology Fellowship Summary of Year-Long Curriculum
OVERVIEW OF THE FELLOWSHIP The goal of the AASLD NP/PA Fellowship is to provide a 1-year postgraduate hepatology training program for nurse practitioners and physician assistants in a clinical outpatient
MEDICAL POLICY No. 91104-R7 DETOXIFICATION I. POLICY/CRITERIA
DETOXIFICATION MEDICAL POLICY Effective Date: January 7, 2013 Review Dates: 1/93, 2/97, 4/99, 2/01, 12/01, 2/02, 2/03, 1/04, 1/05, 12/05, 12/06, 12/07, 12/08, 12/09, 12/10, 12/11, 12/12, 12/13, 11/14 Date
Review Article Hepatic Encephalopathy: From the Pathogenesis to the New Treatments
ISRN Hepatology, Article ID 236268, 16 pages http://dx.doi.org/10.1155/2014/236268 Review Article Hepatic Encephalopathy: From the Pathogenesis to the New Treatments Juan Cordoba 1,2,3 1 Departamento de
New Approaches to Neuroimaging of Progressive Multifocal Leukoencephalopathy. Alexandra Binnie, HMS III Gillian Lieberman, M.D.
New Approaches to Neuroimaging of Progressive Multifocal Leukoencephalopathy Alexandra Binnie, HMS III Gillian Lieberman, M.D. What is Progressive Multifocal Leukoencephalopathy (PML)? A demyelinating
DIAGNOSTIC CRITERIA OF STROKE
DIAGNOSTIC CRITERIA OF STROKE Diagnostic criteria are used to validate clinical diagnoses. Here below MONICA diagnostic criteria are reported. MONICA - MONItoring trends and determinants of CArdiovascular
West Nile Virus Meningoencephalitis: MR Imaging Findings
AJNR Am J Neuroradiol 26:1986 1995, September 2005 West Nile Virus Meningoencephalitis: MR Imaging Findings Kalliopi A. Petropoulou, Steven M. Gordon, Richard A. Prayson, and Paul M. Ruggierri BACKGROUND
Functions of the Brain
Objectives 0 Participants will be able to identify 4 characteristics of a healthy brain. 0 Participants will be able to state the functions of the brain. 0 Participants will be able to identify 3 types
Reversibility of Acute Demyelinating Lesions in relapsingremitting
Reversibility of Acute Demyelinating Lesions in relapsingremitting Multiple Sclerosis Omar A. Khan ( Division of Neuroimmunology, Department of Neurology, Neurology and Research Services. Veterans Affairs
CRISIS COVER CLAIM FORM (DEAFNESS/ PARTIAL LOSS OF HEARING OR CAVERNOUS SINUS THROMBOSIS SURGERY/ COCHLEAR IMPLANT SURGERY) SECTION
Reg. No 199002477Z CRISIS COVER CLAIM FORM (DEAFNESS/ PARTIAL LOSS OF HEARING OR CAVERNOUS SINUS THROMBOSIS SURGERY/ COCHLEAR IMPLANT SURGERY) SECTION 1 This section is to be completed by the Life Assured
Steps to getting a diagnosis: Finding out if it s Alzheimer s Disease.
Steps to getting a diagnosis: Finding out if it s Alzheimer s Disease. Memory loss and changes in mood and behavior are some signs that you or a family member may have Alzheimer s disease. If you have
Chapter 10. Summary & Future perspectives
Summary & Future perspectives 123 Multiple sclerosis is a chronic disorder of the central nervous system, characterized by inflammation and axonal degeneration. All current therapies modulate the peripheral
Short Communications. Alcoholic Intracerebral Hemorrhage
Short Communications 1565 Alcoholic Intracerebral Hemorrhage Leon A. Weisberg, MD Six alcoholic patients developed extensive cerebral hemispheric hemorrhages with both intraventricular and subarachnoid
The State of the Liver in the Adult Patient after Fontan Palliation
The State of the Liver in the Adult Patient after Fontan Palliation Fred Wu, M.D. Boston Adult Congenital Heart Service Boston Children s Hospital/Brigham & Women s Hospital 7 th National Adult Congenital
NUTRITION IN LIVER DISEASES
NUTRITION IN LIVER DISEASES 1. HEPATITIS: Definition: - Viral inflammation of liver cells. Types: a. HAV& HEV, transmitted by fecal-oral route. b. HBV & HCV, transmitted by blood and body fluids. c. HDV
MRI of Bone Marrow Radiologic-Pathologic Correlation
MRI of Bone Marrow Radiologic-Pathologic Correlation Marilyn J. Siegel, M.D. Mallinckrodt Institute of Radiology Washington University School of Medicine St. Louis, MO and Visiting Scientist, AFIP, Washington,
Management in the pre-hospital setting
Management in the pre-hospital setting Inflammation of the joints Two main types: Osteoarthritis - cartilage loss from wear and tear Rheumatoid arthritis - autoimmune disorder Affects all age groups,
Myelinization. THOMAS P. NAIDICH, MD FACR Mt. Sinai Medical Center New York, NY USA
Myelinization THOMAS P. NAIDICH, MD FACR Mt. Sinai Medical Center New York, NY USA ALTERS BRAIN WATER LOCALLY MYELIN CONTAINS: GLYCOLIPIDS PHOSPHOLIPIDS & CHOLESTEROL Maturation of the White Matter Maturation
CSE511 Brain & Memory Modeling. Lect04: Brain & Spine Neuroanatomy
CSE511 Brain & Memory Modeling CSE511 Brain & Memory Modeling Lect02: BOSS Discrete Event Simulator Lect04: Brain & Spine Neuroanatomy Appendix of Purves et al., 4e Larry Wittie Computer Science, StonyBrook
Enjoy a position of vantage, come what may.
Enjoy a position of vantage, come what may. prucrisis covervantage While you have achieved much in life and you and your family enjoy the benefits of success, there may be times when the unexpected happens.
The neuropathology of CJD
The neuropathology of CJD Definitive diagnosis of a human prion disease requires neuropathological examination of the brain of the affected individual. In the laboratory investigation of human prion diseases
Liver Failure. Nora Aziz. www.3bv.org. Bones, Brains & Blood Vessels
Liver Failure Nora Aziz www.3bv.org Bones, Brains & Blood Vessels Severe deterioration in liver function Looses ability to regenerate/repair decompensated Liver extensively damaged before it fails Equal
MANAGEMENT OF LIVER CIRRHOSIS
MANAGEMENT OF LIVER CIRRHOSIS Information Leaflet Your Health. Our Priority. Page 2 of 6 What is cirrhosis? Cirrhosis is a result of long-term, continuous damage to the liver and may be due to many different
Chapter 3 The Anatomy of the Nervous System
Chapter 3 The Anatomy of the Nervous System Systems, Structures, and Cells That Make Up Your Nervous System 1 General Layout of the Nervous System Central Nervous System (CNS) Brain (in the skull) Spinal
A CASE OF LIVER CIRRHOSIS & HEPATIC ENCEPHALOPATHY
A CASE OF LIVER CIRRHOSIS & HEPATIC ENCEPHALOPATHY 2 1 Mr N.N. 56 yr old male. Admitted on 22/03/02. 1 month Hx of abdominal distention, confusion, inability to concentrate and dyspnoea Grade 111. Pmx:
placebo-controlledcontrolled double-blind, blind,
Clinical Potential of Minocycline for Depression with Psychotic Features Tsuyoshi Miyaoka Department of Psychiatry Shimane University School of Medicine Minocycline 1. Second-generation tetracycline which
Stuart B Black MD, FAAN Chief of Neurology Co-Medical Director: Neuroscience Center Baylor University Medical Center at Dallas
Billing and Coding in Neurology and Headache Stuart B Black MD, FAAN Chief of Neurology Co-Medical Director: Neuroscience Center Baylor University Medical Center at Dallas CPT Codes vs. ICD Codes Category
NORD Guides for Physicians #1. Physician s Guide to. Tyrosinemia. Type 1
NORD Guides for Physicians #1 The National Organization for Rare Disorders Physician s Guide to Tyrosinemia Type 1 The original version of this booklet was made possible by donations in honor of Danielle
Wallerian Degeneration and Myelin Loss Secondary to Neuronal and Axonal Degeneration
Chapter 105 Wallerian Degeneration and Myelin Loss Secondary to Neuronal and Axonal Degeneration 105.1 Introduction There are basically two causes of wallerian degeneration in our definition: neuronal
CLINICAL NEUROPHYSIOLOGY
CLINICAL NEUROPHYSIOLOGY Barry S. Oken, MD, Carter D. Wray MD Objectives: 1. Know the role of EMG/NCS in evaluating nerve and muscle function 2. Recognize common EEG findings and their significance 3.
Surgery in Individuals Age 65+ Possible Risks. Possible Benefits. Potential Causes of POCD 11/24/2014. What is POCD?
Surgery in Individuals Age 65+ Postoperative Cognitive Dysfunction in Older Adults Ryan W. Schroeder, Psy.D., LP, ABPP-CN Neuropsychologist & Assistant Professor University of Kansas School of Medicine
{ Rifaximin versus Nonabsorbable Disaccharides for the Treatment of Hepatic Encephalopathy: A Meta Analysis}
{ Rifaximin versus Nonabsorbable Disaccharides for the Treatment of Hepatic Encephalopathy: A Meta Analysis} {Dong Wu, Shu-Mei Wu, Jie Lu, Ying-Qun Zhou, Ling Xu, and Chuan-Yong Guo} Noor Al-Hakami, Pharm
Clinical guidance for MRI referral
MRI for cervical radiculopathy Referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of spine for a patient 16 years or older for suspected: cervical radiculopathy
CAMBRIDGE UNIVERSITY CENTRE FOR BRAIN REPAIR A layman's account of our scientific objectives What is Brain Damage? Many forms of trauma and disease affect the nervous system to produce permanent neurological
What Medical Emergencies Should a Dental Office be Prepared to Handle?
What Medical Emergencies Should a Dental Office be Prepared to Handle? Gary Cuttrell, DDS, JD, University of NM Division of Dental Services Santiago Macias, MD, First Choice Community Healthcare Dentists
Alcohol Withdrawal Syndrome & CIWA Assessment
Alcohol Withdrawal Syndrome & CIWA Assessment Alcohol Withdrawal Syndrome is a set of symptoms that can occur when an individual reduces or stops alcoholic consumption after long periods of use. Prolonged
We understand you want support right from the beginning
PROTECT We understand you want support right from the beginning PRUearly stage crisis cover Should an illness strike, the earlier it is diagnosed, the easier it is to manage and the higher the chances
Oral Zinc Supplementation as an Adjunct Therapy in the Management of Hepatic Encephalopathy: A Randomized Controlled Trial
Oral Zinc Supplementation as an Adjunct Therapy in the Management of Hepatic Encephalopathy: A Randomized Controlled Trial Marcus R. Pereira A. Study Purpose Hepatic encephalopathy is a common complication
Renovascular Hypertension
Renovascular Hypertension Philip Stockwell, MD Assistant Professor of Medicine (Clinical) Warren Alpert School of Medicine Cardiology for the Primary Care Provider September 28, 201 Renovascular Hypertension
Living With Hepatic Encephalopathy (HE)
Living With Hepatic Encephalopathy (HE) What is hepatic encephalopathy (HE)? HE is a condition that occurs in people with advanced cirrhosis or severe liver damage. The damaged liver cannot remove the
FastTest. You ve read the book... ... now test yourself
FastTest You ve read the book...... now test yourself To ensure you have learned the key points that will improve your patient care, read the authors questions below. The answers will refer you back to
Normal Postnatal Development of the Corpus Callosum as Demonstrated by MR Imaging
487 Normal Postnatal Development of the Corpus Callosum as Demonstrated by MR Imaging A. James Barkovich 1, 2 Bent 0, Kjos2,3 Sixty-three patients, 3 days to 12 months old, were examined by MR imaging
Implementing Medical Checkups to Prevent. Sports-Related Injuries and Disorders
Sports-Related Injuries and Disorders Implementing Medical Checkups to Prevent Sports-Related Injuries and Disorders JMAJ 48(1): 1 5, 2005 Hideo MATSUMOTO*, Toshiro OTANI**, Hitoshi ABE*** and Yasunori
Hepatitis C Infections in Oregon September 2014
Public Health Division Hepatitis C Infections in Oregon September 214 Chronic HCV in Oregon Since 25, when positive laboratory results for HCV infection became reportable in Oregon, 47,252 persons with
Multiple Sclerosis: An imaging review and update on new treatments.
Multiple Sclerosis: An imaging review and update on new treatments. Dr Marcus Likeman Consultant Neuroradiologist North Bristol NHS Trust Bristol Royal Hospital for Children MRI appearances - White Matter
NEUROLOCALIZATION MADE EASY
NEUROLOCALIZATION MADE EASY Jared B. Galle, DVM, Diplomate ACVIM (Neurology) Dogwood Veterinary Referral Center 4920 Ann Arbor-Saline Road Ann Arbor, MI 48103 Localizing a neurologic problem to an anatomical
Role of Body Weight Reduction in Obesity-Associated Co-Morbidities
Obesity Role of Body Weight Reduction in JMAJ 48(1): 47 1, 2 Hideaki BUJO Professor, Department of Genome Research and Clinical Application (M6) Graduate School of Medicine, Chiba University Abstract:
Report to the Minister of Justice and Attorney General Public Fatality Inquiry
C ANADA Province of Alberta Report to the Minister of Justice and Attorney General Public Fatality Inquiry Fatality Inquiries Act WHEREAS a Public Inquiry was held at the Calgary Courts Centre in the City
Cholinesterase inhibitors and memantine use for Alzheimer s disease TOPIC REVIEW
Cholinesterase inhibitors and memantine use for Alzheimer s disease TOPIC REVIEW Diagnosis of Dementia : DSM-IV criteria Loss of memory and one or more other cognitive abilities Aphasia Apraxia Agnosia
Disorders Considered. A Brief Synopsis of Select Neurological Disorders. Neurological and Psychiatric Symptoms. Neurological Basis
Disorders Considered A Brief Synopsis of Select Neurological Disorders Four neurological disorders are examined to illustrate pathological conditions that can develop related to course material Myasthenia
Cerebellum and Basal Ganglia
Cerebellum and Basal Ganglia 1 Contents Cerebellum and Basal Ganglia... 1 Introduction... 3 A brief review of cerebellar anatomy... 4 Basic Circuit... 4 Parallel and climbing fiber input has a very different
Martin Jackson. August 2011
Martin Jackson August 2011 Substance Related Brain Injury: Basic Research Findings All neurotoxic substances have an acute intoxicating effect (and withdrawal effect) that produces changes in cognition,
Sheep Brain Dissection Picture Guide
Sheep Brain Dissection Picture Guide Figure 1: Right Hemisphere of Sheep s Brain Figure 2: Underside of Sheep s Brain Figure 3: Saggital cut of Sheep s Brain to reveal subcortical structures Figure 4:
ICD-9-CM coding for patients with Traumatic Brain Injury*
ICD-9-CM coding for patients with Traumatic Brain Injury* The diagnostic code for sequelae of traumatic brain injury is: 907.0 Late effect of intracranial injury without mention of skull fracture (Late
Evidence of Brain Damage after High-altitude Climbing by Means of Magnetic Resonance Imaging
The American Journal of Medicine (2006) 119, 168.e1-168.e6 BRIEF OBSERVATION Evidence of Brain Damage after High-altitude Climbing by Means of Magnetic Resonance Imaging Nicolás Fayed, MD, a Pedro J. Modrego,
STROKE PREVENTION AND TREATMENT MARK FISHER, MD PROFESSOR OF NEUROLOGY UC IRVINE
STROKE PREVENTION AND TREATMENT MARK FISHER, MD PROFESSOR OF NEUROLOGY UC IRVINE CASE REPORT: ACUTE STROKE MANAGEMENT 90 YEAR OLD WOMAN, PREVIOUSLY ACTIVE AND INDEPENDENT, CHRONIC ATRIAL FIBRILLATION,
Risk Insurance Definitions of the Critical Illness benefits. Dr. Eric Starke Insurance Medical Advisor
Risk Insurance Definitions of the Critical Illness benefits Dr. Eric Starke Insurance Medical Advisor Why a Critical Illness benefit? A living benefit for a dreaded disease. Dr. Barnard once said the outcome
75-09.1-08-02. Program criteria. A social detoxi cation program must provide:
CHAPTER 75-09.1-08 SOCIAL DETOXIFICATION ASAM LEVEL III.2-D Section 75-09.1-08-01 De nitions 75-09.1-08-02 Program Criteria 75-09.1-08-03 Provider Criteria 75-09.1-08-04 Admission and Continued Stay Criteria
Alcohol and Brain Damage
Alcohol and Brain Damage By: James L. Holly, MD O God, that men should put an enemy in their mouths to steal away their brains! That we should, with joy, pleasance, revel, and applause, transform ourselves
Neuroimaging Findings in Alcohol- Related Encephalopathies
Neuroradiology/Head and Neck Imaging Review Zuccoli et al. Neuroimaging Findings in Alcohol-Related Encephalopathies Neuroradiology/Head and Neck Imaging Review Neuroimaging Findings in Alcohol- Related
The most serious symptoms of this stage are:
The Natural Progression of Hepatitis C The natural history of hepatitis C looks at the likely outcomes for people infected with the virus if there is no medical intervention. However, the process of trying
Ischemia and Infarction
Harvard-MIT Division of Health Sciences and Technology HST.035: Principle and Practice of Human Pathology Dr. Badizadegan Ischemia and Infarction HST.035 Spring 2003 In the US: ~50% of deaths are due to
III./3.1.2. Parkinsonian syndrome (parkinsonism, atypical parkinsonian disorders) in neurodegenerative diseases
III./3.1.2. Parkinsonian syndrome (parkinsonism, atypical parkinsonian disorders) in neurodegenerative diseases III./3.1.2.1. Multiple System Atrophy (MSA) MSA is a sporadic, adult onset degenerative neurological
We have made the following changes to the Critical Illness events covered under our group critical illness policy.
We have made the following changes to the Critical Illness events covered under our group critical illness policy. March 2015 Because everyone needs a back-up plan 7 New critical illness events added to
The Indiana Trial Lawyer Association s Lifetime Achievement Seminar. Honoring Peter L. Obremsky. May 23-24, 2005
The Indiana Trial Lawyer Association s Lifetime Achievement Seminar Honoring Peter L. Obremsky May 23-24, 2005 The Use of Medical Literature in the Brain Injury Case Thomas C. Doehrman Doehrman-Chamberlain
BACKGROUND MEDIA INFORMATION Fast facts about liver disease
BACKGROUND MEDIA INFORMATION Fast facts about liver disease Liver, or hepatic, disease comprises a wide range of complex conditions that affect the liver. Liver diseases are extremely costly in terms of
Guidance for evaluation of new neurological symptoms in patients receiving TYSABRI
Guidance for evaluation of new neurological symptoms in patients receiving TYSABRI Background information Progressive multifocal leukoencephalopathy (PML) PML is a demyelinating disease that attacks the
Presented by: Jean Yoo-Campbell, Matthew Konerman, Monica Konerman, Jean Yoo Campbell, Christian Gocke, Eunpi Cho Donald Lynch
Bass N.M., et. al. N Engl J Med 2010; 362:1071-1081 Presented by: Jean Yoo-Campbell, Matthew Konerman, Monica Konerman, Jean Yoo Campbell, Christian Gocke, Eunpi Cho Donald Lynch Faculty Advisor: Dr. Fred
2.1 Who first described NMO?
History & Discovery 54 2 History & Discovery 2.1 Who first described NMO? 2.2 What is the difference between NMO and Multiple Sclerosis? 2.3 How common is NMO? 2.4 Who is affected by NMO? 2.1 Who first
Concussion/MTBI Certification Series. Featuring: Frederick R Carrick, DC, PhD Distinguished Professor of Neurology, Life University
Concussion/MTBI Certification Series Featuring: Frederick R Carrick, DC, PhD Distinguished Professor of Neurology, Life University Please note that spaces are limited for this specialty certification program.
Surveillance for Hepatocellular Carcinoma
Surveillance for Hepatocellular Carcinoma Marion G. Peters, MD John V. Carbone, MD, Endowed Chair Professor of Medicine Chief of Hepatology Research University of California San Francisco Recorded on April
Introduction. Case History
NAOSITE: Nagasaki University's Ac Title Author(s) A Case Report of Renal Cell Carcino Shimajiri, Shouhei; Shingaki, Yoshi Masaya; Tamamoto, Tooru; Toda, Taka Citation Acta Medica Nagasakiensia. 1992, 37
What do we mean by birth asphyxia
Neonatal Medicine and brain injury in the Infant at term Andrew Whitelaw Professor of Neonatal Medicine University of Bristol What do we mean by birth asphyxia Interruption in oxygen delivery to the fetus
Victorian Additions to the Australian Coding Standards
Victorian Additions to the Australian Coding Standards 1 July 2014 The following are the Victorian Additions to Australian Coding Standards, effective 1 July 2014 (supplementing Australian Coding Standards,
MS ECHO: Update on MS treatment. Gary Stobbe, MD Medical Director, MS Project ECHO Clinical Assistant Professor, UW Neurology 10 14 2015
MS ECHO: Update on MS treatment Gary Stobbe, MD Medical Director, MS Project ECHO Clinical Assistant Professor, UW Neurology 10 14 2015 Conflict of Interest Dr. Stobbe has no conflicts of interest to disclose
Cerebral palsy, neonatal death and stillbirth rates Victoria, 1973-1999
Cerebral Palsy: Aetiology, Associated Problems and Management Lecture for FRACP candidates July 2010 Definitions and prevalence Risk factors and aetiology Associated problems Management options Cerebral
THE ENDOCANNABINOID SYSTEM AS A THERAPEUTIC TARGET FOR LIVER DISEASES. Key Points
December 2008 (Vol. 1, Issue 3, pages 36-40) THE ENDOCANNABINOID SYSTEM AS A THERAPEUTIC TARGET FOR LIVER DISEASES By Sophie Lotersztajn, PhD, Ariane Mallat, MD, PhD Inserm U841, Hôpital Henri Mondor,
IKHLASlink Comprehensive Critical Illness Benefit Secure Takaful Rider
IKHLASlink Comprehensive Critical Illness Benefit Secure Takaful Rider 1. IKHLASlink Comprehensive Critical Illness Benefit Secure Takaful Rider Securing life uncertainties. With IKHLASlink Comprehensive
09/05/2014. Painting pictures of the brain with numbers. Overview
Painting pictures of the brain with numbers Neurology for Insurers Dr Ian Cox & Adele Groyer (Gen Re) Overview Critical Illness Product Background Why should we be interested in neurology? Consult our
